SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.761-0.6%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Caradonna who wrote (3242)12/5/1996 12:46:00 PM
From: b muller   of 14328
 
peter
here is an interesting use for saliva
I think Avit is finally on there way

Thursday December 5 10:47 AM EDT

Avitar to market saliva collection system for DNA testing

WALLINGFORD, Conn.--(BUSINESS WIRE)--December 5, 1996--Avitar, Inc. (Nasdaq SmallCap Market:AVIT
(Common Stock); AVITW (Redeemable Warrants)) announced today that it has begun to market a version of its saliva
collection system specifically for use in the DNA testing market. The system will be sold for use as a component in the
performance of DNA amplification techniques such as PCR, as well as others.

These DNA tests are used for the determination of paternity, the detection of genetic disorders, the detection of infectious
diseases, and forensics.

Peter Phildius, Chairman and CEO of Avitar, commented, "This expansion of our sample collection technology into the
DNA testing market is exciting. Early feedback from prospective customers indicates that they believe the product has
advantages over existing methods and is more cost-effective. The dramatic growth in this field in recent years offers
Avitar a significant market opportunity. This, combined with our previously-announced entry into the non-invasive
diagnostic testing market, positions Avitar to leverage its technology in this rapidly-growing segment of the medical
market."

Avitar, Inc. designs, develops, manufactures and markets healthcare products and services including Hydrasorb(TM), a
proprietary line of polyurethane wound care dressings. The Company also provides healthcare cost containment services
to employers and third-party payers.

CONTACT: AVITAR, INC.
Peter Phildius, 617/821-2440
Jay Leatherman, 203/265-3594
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext